Apimeds Us I trades -8.54 percent lower on Monday 26th of October
Apimeds US I stock drops 8.54% to $2.92—market cap $4.4 M, 200‑day SMA $11.25. Explore recent performance and compare with peers like Boku, Cardio Diagnostics, and HCTI.
- APIMEDS PHARMACEUTICALS US I
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read